Join
Live feed
·
PRReleasevia Quantisnow
BioVie Inc. logo

BioVie Announces First Patient Enrolled in BIV201 Phase 2b Clinical Trial for Ascites

ByQuantisnow·Wall Street's wire, on your screen.
BIVI· BioVie Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BIVI (BioVie Inc.) and more on Quantisnow.